Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
234 studies found for:    "capillary malformation-arteriovenous malformation syndrome" OR "Vascular Malformations"
Show Display Options
RSS Create an RSS feed from your search for:
"capillary malformation-arteriovenous malformation syndrome" OR "Vascular Malformations"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Cryoablation of Venous Vascular Malformations
Condition: Venous Vascular Malformation
Intervention: Device: Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)
2 Recruiting suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Condition: Vascular Malformation
Intervention: Drug: Sirolimus
3 Not yet recruiting the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Intervention: Device: balloon assisted enteroscopy
4 Recruiting the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Interventions: Drug: Thalidomide (100mg);   Drug: Thalidomide (50mg);   Drug: placebo
5 Recruiting Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Condition: Vascular Malformations
Intervention: Drug: Sirolimus
6 Withdrawn Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Conditions: Gastrointestinal Hemorrhage;   Vascular Malformation
Interventions: Drug: Thalidomide;   Drug: Placebo
7 Withdrawn Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Conditions: Gastrointestinal Bleeding of Unknown Origin;   Gastrointestinal Vascular Malformation;   Thalidomide Efficiency
Interventions: Drug: Thalidomide;   Other: Placebo
8 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
9 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample
10 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
11 Recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
12 Completed Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
13 Completed
Has Results
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Conditions: Obscure Gastrointestinal Bleeding;   Angiodysplasia;   Gastric Antral Vascular Ectasia;   Thalidomide
Interventions: Drug: Thalidomide;   Drug: Iron
14 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
15 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
16 Completed Safety of Apollo Micro Catheter in Pediatric Patients
Conditions: Brain Arteriovenous Malformation;   Brain Vascular Malformations;   Vein of Galen Malformation
Intervention: Device: Apollo Micro Catheter device
17 Not yet recruiting Electrosclerotherapy for Capillary Malformations
Conditions: Capillary Malformations;   Vascular Malformations
Interventions: Other: Electrosclerotherapy;   Drug: Intralesional bleomycin injection
18 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
19 Recruiting Registry for Vascular Anomalies Associated With Coagulopathy
Conditions: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia;   Cutaneovisceral Angiomatosis With Thrombocytopenia;   Vascular Anomaly With Thrombocytopenia;   Hemangiomas
Intervention: Other: no intervention
20 Active, not recruiting Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendotheliomas;   Tufted Angioma;   Capillary Venous Lymphatic Malformation;   Venous Lymphatic Malformation;   Microcystic Lymphatic Malformation;   Mucocutaneous Lymphangiomatosis and Thrombocytopenia;   Capillary Lymphatic Arterial Venous Malformations;   PTEN Overgrowth Syndrome With Vascular Anomaly;   Lymphangiectasia Syndromes
Intervention: Drug: sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.